Coinbase stock in focus after CEO Armstrong pulls backing for Senate crypto bill draft

Coinbase stock in focus after CEO Armstrong pulls backing for Senate crypto bill draft

Coinbase CEO Brian Armstrong withdrew support for the Senate’s latest crypto market-structure bill, citing “too many issues” ahead of a key committee markup Thursday. The draft would restrict stablecoin interest payments and expand SEC oversight, drawing mixed industry reactions. Lawmakers remain divided over stablecoin rules and regulatory authority as the Senate Banking Committee prepares to meet.
Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals (CRML) jumps after Greenland drill assays — what to watch next

Critical Metals shares surged 33% to $17.93 in after-hours trading Wednesday after releasing new drill assay results from its Tanbreez rare earth project in Greenland. Around 60 million shares traded hands amid heavy volatility. The company reported steady grades and significant heavy rare earth content, with more assay results pending. President Trump delayed tariffs on rare earths and lithium, urging officials to secure supplies abroad.
15 January 2026
Circle stock (CRCL) rises after-hours as stablecoin regulation battle returns to Washington

Circle stock (CRCL) rises after-hours as stablecoin regulation battle returns to Washington

Circle Internet Group shares rose 1.7% in after-hours trading Wednesday, closing at $84.80. The move followed a Senate draft bill proposing new rules for stablecoins and crypto markets, including limits on interest payments. Circle reported $9.6 trillion in USDC onchain volume for Q3 2025. Polygon Labs announced a $250 million deal to acquire Coinme and Sequence to expand stablecoin payments.
AbbVie stock in focus after hours as it eyes obesity market — what to watch next

AbbVie stock in focus after hours as it eyes obesity market — what to watch next

AbbVie shares rose about 0.5% to $221.89 in after-hours trading Wednesday after executives outlined plans to expand into obesity treatments. The company is betting on GUBamy, a drug licensed from Denmark’s Gubra, and highlighted its focus on amylin-based therapies. Investors are watching for pricing pressure from Washington ahead of AbbVie’s Feb. 4 earnings report.
Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

Lockheed Martin stock jumps after hypersonic missile engine test with GE, Stinger-replacement flight milestone

Lockheed Martin shares rose 2.6% in after-hours trading Wednesday after it and GE Aerospace announced successful tests of a new ramjet engine for hypersonic missiles. Citi raised its price target for Lockheed to $592 ahead of the Jan. 29 earnings call. Northrop Grumman, RTX, and General Dynamics also gained, while GE Aerospace slipped 2.5%.
D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave (QBTS) stock jumps after hours as Honeywell’s Quantinuum IPO plan jolts quantum names

D-Wave Quantum shares rose 4.7% to $30.15 in after-hours trading Wednesday after Honeywell said its Quantinuum unit plans to file confidential IPO documents with the SEC. Other U.S. quantum stocks, including IonQ and Rigetti, also gained. D-Wave’s $550 million acquisition of Quantum Circuits is expected to close by late January, pending approvals. Traders are watching for D-Wave’s upcoming user conference and the Quantum Circuits deal.
EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review

EchoStar Corporation (SATS) stock jumps nearly 6% as Dish vendor dispute hits FCC SpaceX review

EchoStar shares jumped 5.9% to $131.09 in after-hours trading following news that Crown Castle accused Dish Wireless of defaulting on over $3.5 billion in payments. Crown Castle has ended its infrastructure deal with Dish and, along with other vendors, is urging the FCC to impose conditions on EchoStar’s pending spectrum transfer to SpaceX. The FCC’s timeline for spectrum transfers and earnings forecasts remains in focus.
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher shares closed up 2.4% at $621.83 Wednesday and held steady after hours, following news of new U.S. drug manufacturing contracts. CEO Marc Casper cited a focus on reshoring production from Europe and Asia. A recent SEC filing detailed leadership changes effective in March, including COO Michel Lagarde’s exit. The company also announced a partnership with Nvidia to expand AI in lab automation.
UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth stock in focus after rural hospital payment pilot — and a Senate Medicare report

UnitedHealth shares rose 0.3% to $334.96 in after-hours trading after its UnitedHealthcare unit launched a pilot to speed Medicare Advantage payments to rural hospitals. The move comes as a Senate committee report accuses UnitedHealth of inflating reimbursements through aggressive coding, which the company disputes. Investors await UnitedHealth’s 2026 outlook on Jan. 27.
15 January 2026
Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley stock slips before earnings as Wall Street digests big-bank signals

Morgan Stanley shares fell 1.1% to $180.78 Wednesday, lagging peers ahead of its quarterly earnings due before Thursday’s open. Investors are focused on trading and wealth management results after a sector rally and mixed bank earnings. After-hours trading showed little movement. U.S. bank stocks slipped as policy uncertainty and uneven results weighed on sentiment.

Stock Market Today

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop